89 related articles for article (PubMed ID: 2879850)
1. Reversibility of hemodynamic hypofrontality in schizophrenia.
Geraud G; Arné-Bès MC; Güell A; Bes A
J Cereb Blood Flow Metab; 1987 Feb; 7(1):9-12. PubMed ID: 2879850
[TBL] [Abstract][Full Text] [Related]
2. Effects of age, neuropsychological impairment, and medication on regional cerebral blood flow in schizophrenia and major affective disorder.
Goldstein PC; Brown GG; Marcus A; Ewing JR
Henry Ford Hosp Med J; 1990; 38(4):202-6. PubMed ID: 1982284
[TBL] [Abstract][Full Text] [Related]
3. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
5. [Frontal lobe hypoactivity in schizophrenia: change in perspective].
Laplante L; Everett J
J Psychiatry Neurosci; 1992 Nov; 17(5):199-205. PubMed ID: 1489762
[TBL] [Abstract][Full Text] [Related]
6. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia.
Berman KF; Torrey EF; Daniel DG; Weinberger DR
Arch Gen Psychiatry; 1992 Dec; 49(12):927-34. PubMed ID: 1360197
[TBL] [Abstract][Full Text] [Related]
7. Regional cerebral blood flow SPECT study, at rest and during Wisconsin Card Sorting Test (WCST) performance, in schizophrenia naive patients or treated with atypical neuroleptics.
Moreno-Iñiguez M; Ortuño F; Arbizu J; Millán M; Soutullo C; Cervera-Enguix S
Actas Esp Psiquiatr; 2005; 33(6):343-51. PubMed ID: 16292718
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
Hernandez I; Sokolov BP
J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
[TBL] [Abstract][Full Text] [Related]
10. Dopamine, the prefrontal cortex and schizophrenia.
Knable MB; Weinberger DR
J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
[TBL] [Abstract][Full Text] [Related]
11. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies.
Hill K; Mann L; Laws KR; Stephenson CM; Nimmo-Smith I; McKenna PJ
Acta Psychiatr Scand; 2004 Oct; 110(4):243-56. PubMed ID: 15352925
[TBL] [Abstract][Full Text] [Related]
12. Resting hypofrontality in schizophrenia: A study using near-infrared time-resolved spectroscopy.
Hoshi Y; Shinba T; Sato C; Doi N
Schizophr Res; 2006 Jun; 84(2-3):411-20. PubMed ID: 16626944
[TBL] [Abstract][Full Text] [Related]
13. Effects of a dopaminergic agonist (piribedil) on cerebral blood flow in man.
Güell A; Géraud G; Jauzac P; Victor G; Arné-Bès MC
J Cereb Blood Flow Metab; 1982; 2(2):255-7. PubMed ID: 7076737
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
15. [Effects of neuroleptics on the frontal functions of schizophrenics].
Verdoux H; Magnin E; Bourgeois M
Ann Med Psychol (Paris); 1994 Oct; 152(8):530-4. PubMed ID: 7818228
[No Abstract] [Full Text] [Related]
16. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
Himelhoch S; Taylor SF; Goldman RS; Tandon R
Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
[No Abstract] [Full Text] [Related]
17. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Siergiejczyk L; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():11-6. PubMed ID: 17507879
[TBL] [Abstract][Full Text] [Related]
18. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
Maćkowiak M; Czyrak A; Wedzony K
Psychiatr Pol; 2000; 34(4):607-21. PubMed ID: 11059260
[TBL] [Abstract][Full Text] [Related]
19. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Semkovska M; Bédard MA; Stip E
Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
[TBL] [Abstract][Full Text] [Related]
20. [MRI findings in schizophrenic patient with frontal lobe atrophy].
Kimura N; Inayama Y; Shigenobu K; Kakiuchi Y; Tabushi K
Seishin Shinkeigaku Zasshi; 2004; 106(2):152-60. PubMed ID: 15052786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
